Research assistant position. Dr Rami Al Batran laboratory
Research assistant, part time.
Dr Rami Al Batran laboratory, Université de Montréal.
For more information please click here.
Research assistant, part time.
Dr Rami Al Batran laboratory, Université de Montréal.
For more information please click here.
Postdoctoral position.
Dr Guy Rutter laboratory, Montreal Diabetes Research Center, CRCHUM.
For more information, please click here.
Postdoctoral position.
Dr Corinne Hoesli laboratory, McGill University.
For more information, please click here.
Postdoctoral position.
Dr Vincent Poitout laboratory, CRCHUM, Université de Montréal.
For more information, please click here.
Ph.D. candidate position
Dr. Shao-Ling Zhang laboratory, CRCHUM
For more information, please click here.
Ph.D. candidate position
Dr. Vincent Poitout laboratory, CRCHUM
For more information, please click here.
2020 MDRC Annual Scientific Meeting
The 14th Annual Scientific Meeting of the Montreal Diabetes Research Center will be held on January 31st, 2020.
This year we will have the privilege to welcome Dr Kevin D. Hall, who will give the J. Denis McGarry MDRC Lecture and Dr Robert O. Wright, who will give the George Cahill Jr Lecture.
The retreat is supported by generous contributions from:
Dr Kana N. Miyata, post-doc in John Chan lab (CRCHUM), has received the prestigious Ben J. Lipps Research Fellowship Award from the American Society of Nephrology (ASN) Foundation. For more information, please visit the ASN website.
2019 MDRC Annual Scientific Meeting.
This year at the 13th Annual Scientific Meeting on February 1st, 2019, we will have the privilege to welcome Dre Nancy Cox, who will give the J. Denis McGary MDRC Lecture and Dre Elizabeth Meyer-Davis will give the George Cahill Lecture. We have a new addition this year, The Martin Rodbell Translational Research Lecture, to be given by Dr. Jean-Claude Tardif.
Over $2.5 million to Rémi Rabasa-Lhoret for research on the artificial pancreas.
Dr Rémi Rabasa-Lhoret research team at IRCM is receiving a grant of more than $2.5M USD from the U.S. NIH for a clinical study on external artificial pancreas. The goal of the project is to compare glucose control achieved using the single-hormone (insulin only) artificial pancreas, the dual-hormone (insulin and glucagon) artificial pancreas, and the conventional insulin pump to deliver insulin.
Dr Rabasa-Lhoret team is leading the field of artificial pancreas development in Canada, a technology which has the potential to greatly reduce complication risks associated to a poor glucose control in people with type 1 diabetes. Click here for the IRCM news release.
MDRC annual retreat is scheduled for February 6, 2015. It will be held in the auditorium of the new CHUM research center, 900 St-Denis Street. Dr Philipp Scherer from the Southwestern Medical Center in Dallas is the invited speaker for the “2015 J Denis McGarry Lecture”.
Since last year the MDRC is proud to also present a major Lecture in clinical research, the “George Cahill Lecture”. Our second invited speaker is Dr Ralph DeFronzo from the Health Science Center in San Antonio. Oral and poster presentations by MDRC students and trainees are scheduled, as well as a presentation by Dr Philippe Crine, from Enobia Inc.
Please register as soon as possible through the form available here. Students and post-docs interested in giving an oral or poster presentation must submit their abstract through the same form before January 18, 2014.
The program will be available soon.
The 2015 Annual Retreat is sponsored by Merck, AstraZeneca, Novo Nordisk, Janssen, Boehringer, Sanofi, McGill University Faculty of Medicine, Réseau de Recherche en Santé Cardiométabolique Diabète et Obésité (CMDO), IRCM, Diabète Québec and CRCHUM.
In recognition of the MDRC success at the Canada Foundation for Innovation competition, the Faculté de Médecine de l’Université de Montréal generously gives us $40,000 in funding for Msc and PhD students. Thanks to this support, 4 studentships of $10,000 are awarded each year.
Here are the 2014-2015 recipients:
The Alberta Diabetes Institute is introducing a competition to offer 2 visiting scientist awards at a maximum of $10,000 each, so that scientists at any level can spend up to 4 months in Edmonton, Alberta, Canada carrying out their own research projects on human islets.
For more details please download this document or visit Dr Patrick MacDonald lab website. Deadline for application is January 31, 2015.
A new study conducted by MDRC member Dr May Faraj, shows that the number of low-density lipoprotein particles carrying bad cholesterol in the blood is an important factor in promoting the risk for type 2 diabetes in obese individuals. Their results are published in the May 2013 issue of the Journal of Lipid Research. This scientific breakthrough may help prevent diabetes by targeting treatments to higher-risk individuals. Click here for more details.
Two projects of the MDRC researchers Marc Prentki and Nabil Seidah have recently been funded by the venture capital fund AmorChem: more than 1 million and 1.5 million $, respectively. The shareholders of this fund are the Quebec government, Fonds de solidarité FTQ and Merck. The mission of AmorChem is to increase the commercial value of academic research discoveries in Quebec. Click here for an article in La Presse about this news (in French).
AmorChem venture capital fund invests at MDRC.
Two projects of the MDRC researchers Marc Prentki and Nabil Seidah have recently been funded by the venture capital fund AmorChem: more than 1 million and 1.5 million $, respectively. The shareholders of this fund are the Quebec government, Fonds de solidarité FTQ and Merck. The mission of AmorChem is to increase the commercial value of academic research discoveries in Quebec.
Click here for an article in La Presse about this news (in French).
The Canada Foundation for Innovation (CFI) announced last January 15 the attribution of a 6.5 million $ grant to fund the project entitled “The Montreal Cardiometabolic biomarker and drug discovery consortium (BIOcMET)”. This project is led by Dr Marc Prentki, MDRC director. Among the 10 investigators involved in the project, 8 are MDRC members: Drs Prentki, Poitout, Hamet, Turgeon, Gaudreau (UdM/CRCHUM), Rabasa-Lhoret, Seidah (UdM/IRCM) and Sladek (McGill). The two other researchers are Drs Blanchette (McGill) and Coulombe (UdM/IRCM).
MDRC Director Marc Prentki has been awarded the 2011 Albert Renold Prize by the European Association for the Study of Diabetes (EASD) for “outstanding achievements in research on the islets of Langerhans”.
As part of the prize Dr Prentki was invited to give the Albert Renold Lecture at the 2011 EASD annual meeting. The title of his talk was: “Tricycling along the β-cell and its coupling mechanisms for fuel induced insulin secretion”.